Activity of high dose daptomycin, vancomycin and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.

08:05 EST 31st January 2015 | BioPortfolio

Summary of "Activity of high dose daptomycin, vancomycin and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm."

Biofilm is an important virulence factor that allows bacteria to resist host responses and antibacterial agents. The aim of the study was to assess the in-vitro activity of several antimicrobials alone or in combination against two Staphylococcus aureus isolates using a novel pharmacokinetic/pharmacodynamic model of biofilm for three days. One methicillin-susceptible S. aureus (SH1000) and one methicillin-resistant S. aureus (N315) were evaluated in a modified biofilm reactor with polystyrene coupons. Simulated regimens included vancomycin (VAN) plus RIF, moxifloxacin (MOX) and high dose (10 mg/kg/day) daptomycin (DAP) alone and combined with rifampin (RIF) or clarithromycin (CLA). Against SH1000 viable planktonic (PB) and biofilm-embedded bacteria (BB), neither DAP nor MOX alone were bactericidal. In contrast, combination of DAP and MOX with CLA significantly increased the activity of the two agents against both PB and BB (p<0.01), and DAP+CLA reached the limit of detection at 72h. Against PB of N315, DAP alone briefly achieved bactericidal activity at 24h, whereas sustained cidal activity was observed at 32h with VAN+RIF. Overall, only minimal reduction was observed with both regimens against BB (< 2.8 log10 CFU/mL). Finally, combination of DAP+RIF was bactericidal against both PB and BB, achieving the limit of detection at 72h. In conclusion, we developed a novel in-vitro PK/PD model to assess the activity of antimicrobials against mature bacterial biofilm. Combinations of DAP or MOX with CLA were the most effective regimens and may represent promising options to treat persistent infections caused by S. aureus biofilms.


Wayne State University, Anti-Infective Research Laboratory, Detroit, MI USA; Infectious Diseases Unit, HU San Cecilio, Granada-Spain; University of Wisconsin, Madison, WI. USA.

Journal Details

This article was published in the following journal.

Name: Antimicrobial agents and chemotherapy
ISSN: 1098-6596


PubMed Articles [26433 Associated PubMed Articles listed on BioPortfolio]

Activity of Daptomycin or Linezolid in Combination with Rifampin or Gentamicin against Biofilm-forming Enterococcus faecalis or E. faecium in an In Vitro Pharmacodynamic Model using Simulated Endocardial Vegetations and In Vivo Survival Assay using Galleria mellonella Larvae.

Enterococci are the third most frequent cause of infective endocarditis. A high-inoculum stationary phase in vitro pharmacodynamic model with simulated endocardial vegetations was used to simulate hum...

The pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosis.

 Moxifloxacin is currently recommended at a dose of 7.5-10 mg/kg for children with multidrug-resistant (MDR)-TB, but pharmacokinetic and long-term safety data of moxifloxacin in children with tuberc...

Does moxifloxacin alter oxidant status in the cornea? An experimental study.

Abstract Objective: In this experimental study, we investigated the possible effects of intracameral moxifloxacin on oxidative stress parameters and endothelial cell morphology in corneal tissue. Meth...

Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum… a cautionary tale.

The objective of this study was to investigate the observation of daptomycin resistance in Corynebacterium striatum, both in vivo and in vitro. We describe a case of C. striatum bacteremia in a patien...

High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis.

Background Tuberculosis regimens that are shorter and simpler than the current 6-month daily regimen are needed. Methods We randomly assigned patients with newly diagnosed, smear-positive, drug-sensit...

Clinical Trials [6033 Associated Clinical Trials listed on BioPortfolio]

A Study to Evaluate Daptomycin Given During Dialysis and After Dialysis

The purpose of this study is to determine whether daptomycin at a higher dose given during the last 30 minutes of a dialysis session is equal to a lower dose of daptomycin given after a di...

Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections

Daptomycin is a new antimicrobial agent which has activity against resistant Gram positive cocci including MRSA. The phase 3 clinical trials for skin and soft tissue infections (SSTI) with...

Pharmacokinetic Study of Daptomycin in Healthy Chinese Subjects Living in China

The primary objective of this study is to characterise the pharmacokinetics and dose proportionality of daptomycin after single and multiple (once daily) 4mg/kg and 6 mg/kg doses of daptom...

Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis

multicenter, randomized, double blind study to describe the safety and efficacy of daptomycin (6 mg/kg q24h) with and without concomitant initial gentamicin combination therapy in the trea...

Moxifloxacin Prophylaxis: Moxifloxacin in the Prevention of Bacteremia After High-Dose Chemotherapy and Transplantation of Peripheral Stem Cells

This study investigates whether the prophylactic use of moxifloxacin during high-dose chemotherapy followed by autologous stem cell transplantation reduces the incidence of clinically sign...

Medical and Biotech [MESH] Definitions

The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population.

Mice selectively bred for hypersusceptibility to two-stage chemical skin carcinogenesis. They are also hypersusceptible to UV radiation tumorigenesis with single high-dose, but not chronic low-dose, exposures. SENCAR (SENsitive to CARcinogenesis) mice are used in research as an animal model for tumor production.

The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc.

The use of multiple drugs administered to the same patient, most commonly seen in elderly patients. It includes also the administration of excessive medication. Since in the United States most drugs are dispensed as single-agent formulations, polypharmacy, though using many drugs administered to the same patient, must be differentiated from DRUG COMBINATIONS, single preparations containing two or more drugs as a fixed dose, and from DRUG THERAPY, COMBINATION, two or more drugs administered separately for a combined effect. (From Segen, Dictionary of Modern Medicine, 1992)

A cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA.

Search BioPortfolio:

Relevant Topic

Public Health
Latest News Clinical Trials Research Drugs Reports Corporate
Public health is the scientific, political and sociological approach by a society to maximise the health of the population through disease preventaion and mainenance of healthy life-styles. The mains areas of public health are epidemiology, biostatistics...